生成式AI赋能数字化心理治疗，「望里科技」获数千万元B+轮融资丨早起看早期

Core Viewpoint - Wangli Technology has developed a digital therapy software for depression symptoms, which has received approval as a Class III medical device, marking a significant milestone in the digital mental health treatment sector in China [2][5]. Group 1: Company Overview - Wangli Technology has completed a B+ round financing of several tens of millions, led by Yuan Yi Capital, with funds primarily allocated for product development [3]. - The company has built a database with 300,000 real-world patient data points and has published over ten papers in international psychiatric journals [3]. - Wangli Technology offers a comprehensive solution for various industry clients, combining professional equipment, an app, and trained personnel, covering over 100 cities across 16 provinces in China [3]. Group 2: Product Development - The "Wangli Warm Sun" (WL-iCBT) software, designed for digital psychological treatment, integrates evidence-based multimodal cognitive behavioral therapy and cognitive improvement training, allowing for personalized treatment adjustments [4][5]. - The software's unique treatment optimization algorithm utilizes reinforcement learning and dynamic intervention theories to provide tailored interventions based on real-time user status changes [4]. Group 3: Clinical Trials and Regulatory Approval - The clinical trial for "Wangli Warm Sun" involved 11 hospitals and was led by the National Center for Mental Disorders, focusing on evaluating efficacy, safety, and compliance [5]. - The product has been recommended as a 1A-level treatment method in the 2025 version of the "Guidelines for the Prevention and Treatment of Depression" in China, indicating a clear commercialization path [5].